Rubius Therapeutics, Inc. Gains 29.43%

Fri, Feb 26, 2021 at 05:30 PM
Rubius Therapeutics, Inc. Gains 29.43%

Rubius Therapeutics, Inc. (RUBY:NASDAQ) rocketted at $10.38, representing a gain of 29.4%. On Thu 25 Feb 21, RUBY:NASDAQ touched a New 2-Week Low of $8.02. The stock appeared on our News Catalysts scanner on Thu 18 Feb 21 at 08:34 AM in the 'MISCELLANEOUS' category. From Thu 11 Feb 21, the stock recorded 11.11% Up Days and 10.00% Green Days

The stock spiked on Thu 28 Jan 21 at $15.99 with a volume of 2M+.

About Rubius Therapeutics, Inc. (RUBY:NASDAQ)

Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.